BDC Laboratories Introduces Innovative New Offerings
BDC Laboratories, a recognized leader in cardiovascular device testing solutions, has announced exciting new products that will be on display at MD&M West 2026. This event takes place from February 3 to 5 and is an excellent opportunity for industry professionals to witness advancements in technology for medical device evaluation.
Rapid Silicone Production for Anatomical Models
Among the standout offerings is BDC Laboratories' new rapid silicone production method, which significantly reduces manufacturing lead times for anatomical silicone models. Once the design is finalized, these models can be produced in less than 10 business days. This efficiency applies not only to catalog designs but also to custom geometries provided by customers.
This cutting-edge production technique utilizes optimized methods that ensure high quality while providing rapid results. Customers can expect the same durability and precision that BDC Laboratories is known for, even with faster turnaround times.
According to Bill Carlson, Managing Director of BDC Laboratories, "R&D teams are under constant pressure to iterate designs and generate data quickly. Rapid silicone production offers them a way to compress timelines for anatomical models while maintaining durability and precision with 3D-printed silicones." This innovative approach sets BDC Laboratories apart from competitors that might use off-the-shelf designs or methods that leave undesirable visible layer lines.
Attendees at MD&M West will be able to see examples of anatomies created using this rapid production process, showcasing the capabilities and benefits that these models can provide in R&D settings.
VDT and RWT Software Upgrade for Enhanced Testing
In addition to rapid silicone models, BDC Laboratories is introducing an exciting software upgrade for their VDT-3600i Heart Valve Durability System and RWT-4600i Heart Valve Real-Time Wear System. This software provides engineers with essential tools, such as a high-speed camera and dedicated lighting, facilitating clearer images of valve performance during accelerated wear testing.
This upgrade also includes geometric orifice area (GOA) analysis, which allows for in-depth performance evaluation during testing phases. BDC Laboratories plans to provide a full testing setup at MD&M West, complete with live visualizations. Attendees can see the systems in action, offering a firsthand look at the enhanced capabilities.
We invite visitors to meet the BDC Laboratories team at Booth 1433 at MD&M West. For those interested in scheduling a demonstration, further information can be obtained by contacting BDC Laboratories directly.
About BDC Laboratories
BDC Laboratories specializes in providing testing services and products designed to aid in the mechanical and functional evaluation of Class II and Class III medical device technologies. Their focus ranges from bioprosthetic valve testing to silicone vascular models, supporting innovation from the early stages of R&D through to market launch. BDC Laboratories continues to be at the forefront of developing technologies that enhance the evaluation of medical devices, ensuring they meet necessary regulatory standards.
Frequently Asked Questions
What products are BDC Laboratories showcasing at MD&M West?
BDC Laboratories will showcase rapid silicone production models and updated software for VDT and RWT systems, enhancing testing capabilities.
How quickly can BDC Laboratories produce anatomical silicone models?
After finalizing a design, BDC Laboratories can manufacture anatomical silicone models in less than 10 business days.
What advantages does the new software upgrade offer?
The software upgrade integrates a high-speed camera and enhanced lighting, providing clearer visualizations of valve performance during tests.
Where can I see BDC Laboratories' new products?
Visit BDC Laboratories at Booth 1433 at MD&M West to see live demonstrations of their new offerings.
What types of medical devices does BDC Laboratories evaluate?
BDC Laboratories specializes in evaluating Class II and Class III medical device technologies, including bioprosthetic valves and silicone models.
